Dr. Kimberly S. Cruz

Pediatrics
1906 Belleview Ave SE, 
Roanoke, VA 
Clinical Trials:Currently Recruiting for 1 Trial
1906 Belleview Ave SE, 
Roanoke, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kimberly Cruz is a Pediatrics provider in Roanoke, Virginia. Her top area of expertise is Anemia.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1906 Belleview Ave SE, Roanoke, VA 24014
Other Locations
1221 Ne 26th Ave, Pompano Beach, FL 33062

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Single-Ascending and Repeated Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Who Have the PNPLA3 I148M Genotype
A Single-Ascending and Repeated Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Who Have the PNPLA3 I148M Genotype
Enrollment Status: Recruiting
Publish Date: December 09, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)
An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Drug
Study Drug: FT-4202
Study Phase: Phase 3
An Intrapatient Single Dose and Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of GBT021601, a Hemoglobin S Polymerization Inhibitor, in Participants With Sickle Cell Disease (SCD)
An Intrapatient Single Dose and Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of GBT021601, a Hemoglobin S Polymerization Inhibitor, in Participants With Sickle Cell Disease (SCD)
Enrollment Status: Completed
Publish Date: June 10, 2024
Intervention Type: Drug
Study Drug: GBT021601
Study Phase: Phase 1
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Enrollment Status: Completed
Publish Date: May 25, 2023
Intervention Type: Other, Dietary supplement, Combination product
Study Phase: Phase 2
A Single-dose, Open-label, Pharmacokinetic Study of KD025 in Subjects With Normal Hepatic Function & Subjects With Varying Degrees of Hepatic Impairment
A Single-dose, Open-label, Pharmacokinetic Study of KD025 in Subjects With Normal Hepatic Function & Subjects With Varying Degrees of Hepatic Impairment
Enrollment Status: Completed
Publish Date: July 18, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Multicenter, Open-Label, Parallel-Group Study to Assess the Safety and Pharmacokinetics of Oral Epetraborole Tablets in Adult Subjects With Varying Degrees of Renal Function
A Phase 1, Multicenter, Open-Label, Parallel-Group Study to Assess the Safety and Pharmacokinetics of Oral Epetraborole Tablets in Adult Subjects With Varying Degrees of Renal Function
Enrollment Status: Completed
Publish Date: July 15, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis
A Multiple-Dose, Randomized, Placebo-Controlled, Study of LY3462817 or LY3509754 in Patients With Psoriasis
Enrollment Status: Terminated
Publish Date: March 15, 2022
Intervention Type: Drug
Study Drugs: LY3462817-IV, LY3462817-SV
Study Phase: Phase 1
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
Enrollment Status: Withdrawn
Publish Date: December 06, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

2 Total Publications

The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV.
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV.
Journal: Infectious diseases and therapy
Published: June 13, 2025
Similar Doctors
Expertise in
4
conditions
Dr. Emily S. Doherty
Pediatrics | Medical Genetics
Expertise in
4
conditions
Dr. Emily S. Doherty
Pediatrics | Medical Genetics

Carilion Medical Center

4348 Electric Rd, 
Roanoke, VA 
 (2.4 miles away)
540-769-0976
Languages Spoken:
English
See accepted insurances

Emily Doherty is a Pediatrics specialist and a Medical Genetics provider in Roanoke, Virginia. Dr. Doherty is highly rated in 4 conditions, according to our data. Her top areas of expertise are Fabry Disease, Multiple Sulfatase Deficiency, Megalencephalic Leukoencephalopathy with Subcortical Cysts, and Hermansky-Pudlak Syndrome.

Expertise in
2
conditions
Dr. Austin K. Drake
Pediatrics | General Practice
Expertise in
2
conditions
Dr. Austin K. Drake
Pediatrics | General Practice
4348 Electric Rd, 
Roanoke, VA 
 (2.4 miles away)
540-769-0976
Languages Spoken:
English
See accepted insurances

Austin Drake is a primary care provider, a Pediatrics specialist and a General Practice provider in Roanoke, Virginia. Dr. Drake is highly rated in 2 conditions, according to our data. His top areas of expertise are Tularemia, Concussion, and Traumatic Brain Injury.

Expertise in
9
conditions
Dr. Dane Mcbride
Pediatrics
Expertise in
9
conditions
Dr. Dane Mcbride
Pediatrics

Allergy & Immunology PLC.

1505 Franklin Rd SW, 
Roanoke, VA 
 (0.7 miles away)
540-343-7331
Languages Spoken:
English
See accepted insurances

Dane Mcbride is a Pediatrics provider in Roanoke, Virginia. Dr. Mcbride is highly rated in 9 conditions, according to our data. His top areas of expertise are Sinusitis, Allergic Rhinitis, Ozena, and Nonallergic Rhinopathy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cruz's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile